Ledger.Open graph →
SEC Form D · Amendment · filed July 11, 2012

Sprout Pharmaceuticals, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Industry
Pharmaceuticals
Location
RALEIGH, NC
Type

People & firms on this filing (18)

Matthew J. Graver · WEST CONSHOHOCKEN, PAExecNeha D. Markle · WEST CONSHOHOCKEN, PAExec · DirectorDavid A. Wilton · WEST CONSHOHOCKEN, PADirectorSheri L. Schreck · WEST CONSHOHOCKEN, PADirectorFred S. Pruden · Raleigh, NCExecJames R. Symons · Raleigh, NCExecSteven A. Shin · WEST CONSHOHOCKEN, PAExec · DirectorTimothy J. Knierim · WEST CONSHOHOCKEN, PAExecVictoria A. Eckstein · WEST CONSHOHOCKEN, PAExec · DirectorEdward J. Goldstein · WEST CONSHOHOCKEN, PAExec · DirectorMelissa J. Kang · WEST CONSHOHOCKEN, PADirectorPatrick A. Reid · WEST CONSHOHOCKEN, PADirectorRobert J. Creaney · WEST CONSHOHOCKEN, PAExec · DirectorAndrew J. Murray · WEST CONSHOHOCKEN, PADirectorDima E. Skvortsov · WEST CONSHOHOCKEN, PADirectorRyan A. Meredith · WEST CONSHOHOCKEN, PAExecJohn T. Van Wyk · London, United KingdomExecMeng A. Lim · London, United KingdomExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗